CSI GLOBAL HEALTH / THE FUTURE OF LIFE

From the smallest science,
toward the future of life.

From one particle to a healthier world.
Bringing precision medicine together with the wisdom of life
to explore a future of health, longevity and wellbeing.

Research foundations at Okayama University / Medical innovation for the world

Research

Exploring life science and new possibilities for medicine through basic and applied research.

BNCT

Exploring research and technologies related to boron neutron capture therapy (BNCT).

Translational Research

Considering ways to connect discoveries in basic research with clinical applications.

Global Collaboration

Expanding possibilities through dialogue with researchers and specialists around the world.

Medical Innovation

Connecting research and technology to contribute to the future of health and medicine.

OUR PHILOSOPHY

Respecting the order of lifeand expanding the possibilities of health.

Life is an intricate symphony of particles, molecules, cells and ecosystems. Grounded in research and guided by patients' needs, CSI connects medicine, pharmaceutical sciences, physics, engineering and digital science to bring laboratory discoveries to real health challenges.

In the age of AI, we deepen our understanding of life through data, test hypotheses through experiments, and pursue the practical application of research through collaboration across disciplines. With human warmth at the heart of our work, we share the goal of contributing to longer, higher-quality lives.

  • Scientific inquiry
  • Respect for life
  • Open collaboration

Rooted in university research, putting innovation into practice.

A venture originating from Okayama University
CSI Global Health Co., Ltd.

From academic knowledge accumulated on campus to practical work at an entrepreneurial hub, CSI brings together researchers, engineering and industry to expand the possibilities of life sciences through rigorous research and open collaboration.

Okayama University

Okayama University

Exploring possibilities in life sciences and medicine from a foundation in university research.

Research at Okayama University

Research at Okayama University

Exploring research across disciplines, grounded in university research. Photo: Faculty of Science, Okayama University.

CSI Headquarters | Okayama University Incubator

CSI Headquarters | Okayama University Incubator

Based in the Okayama University incubator, connecting research and business.

Inside the Facility

Inside the Facility

Corridors and meeting spaces support daily work and research exchange.

Six fields,one vision for life.

Connecting medicines, imaging, equipment and people around BNCT. We explore precision particle medicine with practical application in view.

BNCT and Precision Particle Medicine

Exploring research that connects medicines, neutron sources and biological evaluation around boron neutron capture therapy.

Boron Agents and Drug Delivery

Studying tumor accumulation and cellular uptake through boron clusters and nanoscale delivery systems.

Molecular Imaging and Quantitative Evaluation

Exploring evaluation methods that trace drug distribution and connect diagnostic and therapeutic research.

Compact Accelerators and Neutron Science

Exploring compact equipment, shielding design and stable neutron generation for research applications.

SiC and Advanced Medical Engineering

Exploring technologies that support medical research equipment through advanced materials and power electronics.

Global Research and Practical Application

Exploring international research collaboration and pathways to bring research outcomes into clinical and social use.

CSI GLOBAL HEALTH

A venture originating from Okayama University

岡山大学

CSI Global Health Co., Ltd.

From academic knowledge accumulated on campus to practical work at an entrepreneurial hub, CSI brings together researchers, engineering and industry to expand the possibilities of life sciences through rigorous research and open collaboration.

Dr Eiji Matsuura's work, grounded in immunology and biochemistry, includes molecular imaging, targeted medicine, BNCT drug delivery systems (DDS), and theranostics. CSI explores pathways for connecting such research findings with clinical applications and medical technology.

Message from the Founder & CEO

Eiji Matsuura, PhD

FOUNDER & CEO

Eiji Matsuura, PhD

Founder & CEO · Professor Emeritus, Okayama University

Research possibilities, toward the future of medicine.

At CSI Global Health, we seek to connect scientific research with clinical translation and international collaboration. Building on a research foundation related to Okayama University, we will continue to foster practical dialogue across medicine, technology and industry, from Japan to the world.

External Evaluation Committee

External expertise informs the evaluation of research and business direction.

Hachiro Sugimoto

Hachiro Sugimoto

Pharmacy and drug discovery

His work includes Alzheimer’s disease research; his profile identifies him as a developer of the Alzheimer’s medicine Aricept.

Wolfgang A. G. Sauerwein

Wolfgang A. G. Sauerwein

BNCT specialist

Professor Emeritus at the University of Duisburg-Essen and Visiting Professor at Okayama University’s Neutron Therapy Research Center. His work includes early European clinical BNCT.

Sylviane Muller

Sylviane Muller

Immunotherapy and drug discovery

Professor at the University of Strasbourg and Emeritus Research Director at CNRS. Her work focuses on immunotherapy and innovative drug discovery.

Rameshwar Patil

Rameshwar Patil

BNCT and nanomedicine

Associate Professor at Loma Linda University. His research includes BNCT, drug delivery, nanomedicine, the blood–brain barrier and brain tumors.

Naoyuki Yamada

BNCT-related patents

Listed as an inventor on BNCT-related patents in J-GLOBAL.

Kirk Guyer

BioMedica Diagnostics Inc. / General Manager

Previously worked in clinical affairs and key account management at Verum Diagnostica. He co-authored a paper on thromboelastography (TEG) in transfusion management for trauma patients.

Luis R. Lopez

Corgenix Medical Corporation / Former CEO & Chairman

Served as CEO and Chairman from 1998 to 2006, then as Chief Medical Officer; stepped down as Chairman in 2009.

Connecting expertise across research settings.

Research on boron agents and DDS benefits from collaboration across drug distribution, molecular imaging and quantitative evaluation. Through equipment briefings by Professor Matsuura, facility visits and team discussions, we share an understanding of research methods and evaluation pathways.

Researchers and visitors receiving an equipment briefing related to BNCTResearchers visiting a research facility

RESEARCHER VOICE / SHIMADZU FEATURE

Discoveries at the molecular scale point toward a healthier, longer life.

Shimadzu's Boomerang Vol. 43 features Professor Eiji Matsuura's work in molecular imaging and drug delivery, and its potential applications in medicine.

Research scenes: facility visits, equipment briefings and team exchange.

DIGITAL SCIENCE & AI

Digital intelligence,a new language for understanding life.

Digital science and life sciences concept
AI × DATA × LIFE SCIENCE

DISCOVER

Discover molecular possibilities

Explore AI-assisted boron drug design and candidate selection, developing testable hypotheses through computation and refining models through experiments.

UNDERSTAND

Understand delivery pathways

Combine molecular imaging with quantitative data to deepen understanding of distribution, uptake and change over time in tissues and cells.

CONNECT

Connect knowledge across disciplines

Bring medicines, beams, materials and biological effects together through standardised data and collaboration, while exploring traceable research evaluation.

Digital science and AI represent a future research vision. Specific activities will be considered through ongoing validation.

Concept for research exchange across borders
ONE PLANET. SHARED HEALTH.

GLOBAL COLLABORATION

Knowledge across borders, health connecting the world.

With Japan as a starting point for research, we envision dialogue with researchers and industry across regions including China, the United States and Europe. Through exchange around shared scientific questions, we will explore possibilities for collaboration across disciplines and regions.

  • Japan
  • Americas
  • Europe
  • China

NEWS & MEDIA / INTERNATIONAL EXCHANGE

News & Media

A record of international exchange and research collaboration

CSI REPORT

Academic exchange between Professor Eiji Matsuura and international research partners

Around life sciences, BNCT and medical innovation, Professor Eiji Matsuura has built academic, technical and industry exchange with specialists in the United States, Germany, France, China and other regions, extending dialogue between research and application.

From research facility visits and expert discussions to dialogue on translating research outcomes, these nine photographs introduce exchanges that share knowledge across disciplines.